LINC02210: A Long Intergenic Non-Protein-Coding RNA and Its Potential as a Drug Target

Target Name: LINC02210

NCBI ID: G147081

LINC02210

Other Name(s): Long intergenic non-protein coding RNA 2210, transcript variant 2 | long intergenic non-protein coding RNA 2210 | CRHR1-IT1 | Long intergenic non-protein coding RNA 2210, transcript variant 3 | Long intergenic non-protein coding RNA 2210, transcript variant 1 | C17orf69 | Long intergenic non-protein coding RNA 2210, transcript variant 4

LINC02210: A Long Intergenic Non-Protein-Coding RNA and Its Potential as a Drug Target

Introduction

LINC02210 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified using RNA sequencing (RNA-seq) data. It is characterized by its unique 3'-end, open reading frame and its absence of protein coding sequences. Despite its small size, LINC02210 has been shown to play a significant role in gene expression and has been implicated in various biological processes, including cell growth, development, and disease.

In this article, we will explore the potential implications of LINC02210 as a drug target and discuss its potential utility in the development of new therapeutic approaches.

Expression and Localization

LINC02210 was identified using RNA-seq data from the RNA-seq dataset from the National Library of Medicine's GenBank. The RNA-seq data revealed that LINC02210 was expressed in a variety of tissues and cells, including brain, heart, liver, and muscle. The expression level of LINC02210 was found to be significantly higher in brain tissue and mouse embryonic stem cells.

LINC02210 is localized to the cytoplasm of the cells. It was observed that the LINC02210 was mainly concentrated in the peroxisomes and endoplasmic reticulum (ER), which are organelles responsible for the synthesis and storage of proteins. These findings suggest that LINC02210 may be involved in the regulation of protein synthesis and may have a localization to specific cellular organelles.

Function and Putative Functions

LINC02210 has been shown to play a role in several biological processes, including cell growth, development, and disease. One of the most significant functions of LINC02210 is its role in cell growth. LINC02210 has been shown to be involved in the regulation of cell proliferation. and has been linked to the G1/S transition, a critical phase of cell growth.

Additionally, LINC02210 has been shown to be involved in the regulation of cell differentiation. LINC02210 has been shown to be expressed in different cell types during the development of tissues and has been implicated in the regulation of cell fate, including the determination of cell types and the establishment of cell-specific gene expression patterns.

In addition to its role in cell growth and differentiation, LINC02210 has also been implicated in the regulation of inflammation and immune response. LINC02210 has been shown to be involved in the regulation of immune cell function and has been linked to the regulation of inflammation.

Potential Therapeutic Applications

The therapeutic potential applications of LINC02210 are vast and varied. One of the most promising applications of LINC02210 is its potential as a drug target. LINC02210 has been shown to play a role in the regulation of multiple cellular processes and its deregulation has been linked to a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

For example, LINC02210 has been shown to be involved in the regulation of cell proliferation and has been linked to the G1/S transition, a critical phase of cell growth. Therefore, small molecules that can inhibit the G1/S transition and prevent cell proliferation may be a promising therapeutic approach for the treatment of cancer.

In addition, LINC02210 has also been shown to be involved in the regulation of cell differentiation and has been implicated in the regulation of cell fate. Therefore, drugs that can

Protein Name: Long Intergenic Non-protein Coding RNA 2210

The "LINC02210 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02210 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets